23 results
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... cyclooxygenase, preventing ... Limited use peri-PCI ... #Antiplatelet #Medications ... Summary #Table #Pharmacology
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology #
Bisphosphonates for Osteoporosis Treatment or Prevention 

Bisphosphonates are common medications used in the treatment and prevention
for Osteoporosis Treatment ... or Prevention ... used in the treatment ... and prevention ... Schedule #Frequency #Pharmacology
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
Postmenopausal Osteoporosis Treatment ... • Recommend pharmacologic ... measures, fall prevention ... benefits and risks of medications ... Postmenopausal #Treatment
A summary of the pharmacologic management of acute bleeding and secondary prevention of bleeds in LVAD
summary of the pharmacologic ... LVAD #Bleeding #Pharmacology ... #Management #Treatment ... #Medications #Secondary ... #Prevention
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
patients with VTE treatment ... approved for these indications ... Here is an overview ... Rivaroxaban #Dosing #Pharmacology
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
This is an overview ... patients genotype, treatment ... ambcarerx #HCV #Medications ... Classes #DAAs #Pharmacology
Triptan Selection - Migraine Management
Choosing triptans:
 • Reponse to given triptan do not predict to others
month to avoid medication-overuse ... response: • Consider preventive ... Migraine #Management #treatment ... #neurology #pharmacology
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Equina Syndrome Overview ... 33,000-100,000 ppl ... 1.5-3.4 million ppl ... bladder for urinary retention ... axial T1 and T2 Treatment
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Encephalitis in HIV-AIDS Indications ... Encephalitis #IDSA #Prevention ... #Treatment #opportunistic ... #pharmacology